Philips North America has been the subject of 23 FDA enforcement/approval records tracked by Argus HQ, compared to 2 for Hikma Pharmaceuticals USA INC.
Hikma Pharmaceuticals USA INC: 0 warning letters, 1 recall, 1 approval record, 0 Form 483s.
Philips North America: 0 warning letters, 23 recalls, 0 approval records, 0 Form 483s.
Side by side
Hikma Pharmaceuticals USA INC — Warning letters0
Philips North America — Warning letters0
Hikma Pharmaceuticals USA INC — Recalls1
Philips North America — Recalls23
Hikma Pharmaceuticals USA INC — Approval records1
Philips North America — Approval records0
Hikma Pharmaceuticals USA INC — Form 483s0
Philips North America — Form 483s0
Timeline
Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"Hikma Pharmaceuticals USA INC vs Philips North America: FDA Enforcement Comparison." Argus HQ, accessed July 15, 2026. https://argushq.ai/compare/hikma-pharmaceuticals-usa-inc-vs-philips-north-america
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗